CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2/3 Study for the Evaluation of Safety and Efficacy of Humacyte's ATEV for Vascular Replacement or Reconstruction in Patients With Life or Limb-threatening Vascular Trauma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03005418
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-07-30T00:06:31.880852+00:00
Published At: 2026-07-29T00:00:00+00:00
Record Updated At: 2026-07-29
Results Posted At: 2026-07-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Trauma", "Vascular System Injury"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-07-29"
protocolSection.identificationModule.nctId: "NCT03005418"
protocolSection.identificationModule.officialTitle: "A Phase 2/3 Study for the Evaluation of Safety and Efficacy of Humacyte\u0027s ATEV for Vascular Replacement or Reconstruction in Patients With Life or Limb-threatening Vascular Trauma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-07-29"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.